دورية أكاديمية

Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

التفاصيل البيبلوغرافية
العنوان: Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
المؤلفون: Loomba, Rohit, Lawitz, Eric J, Frias, Juan Pablo, Ortiz-Lasanta, Grisell, Johansson, Lars, Franey, Bridgette Boggess, Morrow, Linda, Rosenstock, Moti, Hartsfield, Cynthia L, Chen, Chao-Yin, Tseng, Leo, Charlton, R Will, Mansbach, Hank, Margalit, Maya *
المصدر: In The Lancet Gastroenterology & Hepatology February 2023 8(2):120-132
قاعدة البيانات: ScienceDirect
الوصف
تدمد:24681253
DOI:10.1016/S2468-1253(22)00347-8